ImmuneWatch Named "One to Watch 2025" at Antwerp Innovation Night

ImmuneWatch Wins  "One to Watch 2025" Award as promising startup

We are thrilled to announce that ImmuneWatch has been officially recognised as a top emerging innovative player. During the 4th edition of the Antwerp Innovation Night on December 4, 2025, ImmuneWatch was honoured with the "One to Watch 2025" award.

This recognition, presented by Antwerp Smart Region Link (Antwerp SRL), a collaboration between the University of Antwerp and Voka (Chamber of Commerce Antwerp-Waasland), highlights our rapid growth and the transformative potential of our AI-driven technology.

Recognition for Innovation in Immunoinformatics

The "One to Watch" award is reserved for promising startups that demonstrate exceptional innovation and market potential. An external jury selected ImmuneWatch for our pioneering work in developing machine learning algorithms that give better insights in how the human immune system reacts to vaccines and therapies.

"Winning this award confirms that our mission to accelerate drug and vaccine development by obtaining more valuable insights out of TCR repertoires is resonating with the broader innovation community," says Sander Wuyts, CEO of ImmuneWatch. "It is a testament to the hard work of our team and the power of T-cell data to shape the future of medicine."

Transforming How We Understand Immunity

As a spin-off of the University of Antwerp and Antwerp University Hospital, we are bridging the gap between deep-tech AI and clinical application. This award recognises our focused efforts to redefine the future of precision medicine through advanced immunomonitoring for Pharma & Biotech. We are setting a new standard for how companies track immune responses in clinical trials. By leveraging deep learning on T-cell receptor (TCR) repertoires, we enable partners to monitor patient responses with higher resolution, distinguishing true biological signals from noise in complex immunological data.

This award places us alongside other top innovators, such as iFLUX (winner of the Innovation Award), and cements our position as a promising playerin the European deep-tech ecosystem.

Antwerp Innovation Night

We would like to thank Antwerp SRL, Voka, and the University of Antwerp for this recognition, as well as our partners and clients who trust us to unlock the secrets of the immune system.

‍

Are you working on T-cell receptor analysis or vaccine development? Discover why we are the "One to Watch."

• ImmuneWatch DETECT software - Annotate the specificity of your TCRs
• Immunoinformatic service work - Maximise the value of you TCR repertoires